BRY — Bri-Chem Income Statement
0.000.00%
Last trade - 00:00
- CA$7.40m
- CA$38.31m
- CA$106.04m
- 64
- 98
- 11
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 91.7 | 45.2 | 60.4 | 105 | 106 |
Cost of Revenue | |||||
Gross Profit | 16.4 | 7.33 | 12.2 | 21.1 | 18.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 95.5 | 50.1 | 59.3 | 99.2 | 105 |
Operating Profit | -3.73 | -4.92 | 1.15 | 5.27 | 0.85 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.64 | -5.12 | 1.29 | 4.62 | 1.41 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.66 | -5.15 | 1.32 | 8.64 | 0.909 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.66 | -5.15 | 1.32 | 8.64 | 0.909 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.66 | -5.15 | 1.32 | 8.64 | 0.909 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.086 | -0.212 | 0.048 | 0.327 | 0.034 |